Professor of Medicine and Pharmacology, Assistant Dean for Clinical Research, Tullis-Tulane Alumni Chair in Diabetes, Chief Section of Endocrinology & Metabolism
Tulane University Health Sciences Center
New Orleans, Louisiana, United States
Vivian A. Fonseca, MD, FRCP, is professor of medicine and pharmacology, assistant dean for clinical research,
the Tullis-Tulane Alumni Chair in Diabetes, and chief of the Section of Endocrinology & Metabolism at Tulane
University Medical Center in New Orleans, Louisiana. He is the medical director of the Tulane Clinical Trials
Unit and director of the Research Professional Development Core, which runs the Master of Science in Clinical
Research degree course. Dr. Fonseca earned his medical degree at University of Bombay in India and his FRCP
at the Royal College of Physicians of London, where he completed specialist training in internal medicine,
diabetes, and endocrinology. He is a Diplomate of the American Board of Internal Medicine.
Previously, Dr. Fonseca served as the chief of the Division of Endocrinology at Texas A&M School of Medicine and
as a professor of medicine in the Division of Endocrinology at the University of Arkansas for Medical Sciences.
Dr. Fonseca is a past president of the American Diabetes Association (ADA) and former member of its national
board of directors, as well as the ADA’s national leadership council and executive committee. He was formerly
the editor-in-chief of Diabetes Care and the Journal of Diabetes and Its Complications. Dr. Fonseca has served
on the board of directors for the American Association of Clinical Endocrinology and the board of trustees for
the American College of Endocrinology, both organizations for which he has also served on committees writing
guidelines.
Dr. Fonseca is the recipient of many honors and awards, including the Gerald Reaven Distinguished Leader
in Insulin Resistance Award in 2022 and the Banting Medal for Leadership and Service from the ADA in 2012.
He has published nearly 500 papers and review articles and is the editor of the textbook Clinical Diabetes:
Translating Research into Practice.
Disclosure information not submitted.
Mounjaro® (tirzepatide) Product Theater by Lilly USA, Inc.
Thursday, May 9, 2024
10:30 AM – 11:15 AM CDT